Ardelyx (ARDX) FCF Margin Growth (5y) (2018 - 2026)
Ardelyx (ARDX) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ardelyx |
1.49 Bn |
1.25 Bn |
89.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
64,941.00 |
| Dec 31, 2025 |
100,262.00 |
| Sep 30, 2025 |
74,061.00 |
| Jun 30, 2025 |
100,944.00 |
| Mar 31, 2025 |
200,629.00 |
| Dec 31, 2024 |
50,291.00 |
| Sep 30, 2024 |
68,832.00 |
| Jun 30, 2024 |
15.48 Mn |
| Dec 31, 2023 |
2.20 Mn |
| Sep 30, 2023 |
1.57 Mn |
| Jun 30, 2023 |
6.00 Mn |
| Mar 31, 2023 |
-9,849.00 |
| Jun 30, 2020 |
-87,002.00 |
| Mar 31, 2020 |
-191,510.00 |
| Dec 31, 2019 |
-41,887.00 |
| Sep 30, 2019 |
-61,197.00 |
| Jun 30, 2019 |
-15.51 Mn |
| Dec 31, 2018 |
-2.22 Mn |
| Sep 30, 2018 |
-1.57 Mn |
